Hemolysis in Blood Samples in the ER

This study has been completed.
Information provided by (Responsible Party):
Olivier T. Rutschmann, University Hospital, Geneva
ClinicalTrials.gov Identifier:
First received: March 19, 2013
Last updated: November 8, 2013
Last verified: November 2013
In this study, we aim to identify risk factors for hemolysis in blood samples drawn in the ED.

Emergency Service, Hospital
Blood Specimen Collection

Study Type: Observational
Study Design: Observational Model: Cohort
Time Perspective: Prospective

Further study details as provided by University Hospital, Geneva:

Primary Outcome Measures:
  • Hemolysis rate [ Time Frame: 1 day ] [ Designated as safety issue: No ]

Enrollment: 2800
Study Start Date: June 2013
Study Completion Date: October 2013
Primary Completion Date: October 2013 (Final data collection date for primary outcome measure)
ED patients


Ages Eligible for Study:   16 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
All adult (> 16 y) patients admitted in the emergency departement during the study period

Inclusion Criteria:

  • > 16 years

Exclusion Criteria:

  • In vivo hemolysis
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT01815931

University Hospital, Geneva
Geneva, GE, Switzerland, 1211
Sponsors and Collaborators
University Hospital, Geneva
  More Information

Responsible Party: Olivier T. Rutschmann, MD, MPH, University Hospital, Geneva
ClinicalTrials.gov Identifier: NCT01815931     History of Changes
Other Study ID Numbers: SU-032013 
Study First Received: March 19, 2013
Last Updated: November 8, 2013
Health Authority: Switzerland: Ethikkommission

Additional relevant MeSH terms:
Disease Attributes
Pathologic Processes

ClinicalTrials.gov processed this record on May 24, 2016